Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 10,000 LBRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | LB PHARMACEUTICALS INC (LBRX) | Grant/Award | 10,000 | n/a |
| Oct 17, 2025 | Keros Therapeutics, Inc. (KROS) | Sale | 2,284,612 | $40.55M |
| Sep 16, 2025 | LB PHARMACEUTICALS INC (LBRX) | Conversion | 411,681 | n/a |
| Sep 12, 2025 | LB PHARMACEUTICALS INC (LBRX) | Grant/Award | 22,449 | n/a |
| Jun 6, 2025 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 5,250 | n/a |
| Jun 3, 2024 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 10,000 | n/a |
| Jun 8, 2023 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 10,000 | n/a |
| Feb 28, 2023 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 2,211 | $11.1K |
| Nov 30, 2022 | Keros Therapeutics, Inc. (KROS) | In-the-Money Exercise | 3,539 | $0.35 |
| Oct 25, 2022 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 47,999 | $285.1K |